---
document_datetime: 2025-04-30 11:56:20
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/vyvgart-epar-all-authorised-presentations_en.pdf
document_name: vyvgart-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9495427
conversion_datetime: 2025-12-20 10:49:35.738627
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size             |
|------------------|-------------------|------------|---------------------------------------|---------------------------|----------------------------|---------------------------|-----------------------|
| EU/1/22/1674/001 | Vyvgart           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)               | 20 ml                     | 1 vial                |
| EU/1/22/1674/002 | Vyvgart           | 1000 mg    | Solution for injection                | Subcutaneous use          | vial (glass)               | 5.6 ml (180 mg/ml)        | 1 vial                |
| EU/1/22/1674/003 | Vyvgart           | 1000 mg    | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass) | 5.0 ml (200 mg/ml)        | 1 pre-filled syringe  |
| EU/1/22/1674/004 | Vyvgart           | 1000 mg    | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass) | 5.0 ml (200 mg/ml)        | 4 pre-filled syringes |